The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1476
August 31, 2015
View Complete Issue         Table of Contents 2019 
ReShape and Orbera - Two Gastric Balloon Devices for Weight Loss
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
ReShape and Orbera - Two Gastric Balloon Devices for Weight Loss
August 31, 2015 (Issue: 1476)
The FDA has approved the ReShape Integrated Dual Balloon System (ReShape Medical) and the Orbera Intragastric Balloon System (Apollo Endosurgery) for up to 6 months of use in adults with a BMI of 30-40 who have not been able to maintain weight...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: ReShape and Orbera - Two Gastric Balloon Devices for Weight Loss
Article code: 1476c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.